Jola Mehmeti, PharmD, MBA
Jola Mehmeti, PharmD, MBA
Jola Mehmeti is a 2018 PharmD graduate from the UConn School of Pharmacy. She is a PGY1 Clinical Research Pharmacy Resident at Michigan Medicine. Connect with her on LinkedIn or send a message to
Jul 12, 2018 @04:48 AM
Approvals and indications of this drug were based on 3 main clinical trials.

Jul 4, 2018 @02:00 PM
Studying for the MPJE can be daunting. Numerous online threads offer advice on where to start

Jun 27, 2018 @02:25 PM
Food allergens can be present in a variety of medications, but they don't always merit a switch in therapy.

Apr 14, 2018 @12:00 PM
The odorless, bitter, yellow agent known as picric acid was once used in burn relief and surgical procedures.

Mar 22, 2018 @07:20 PM
N-Acetylcysteine has several clinical uses. These include detoxification in acetaminophen overdose and improving outcomes in COPD exacerbations.

Mar 20, 2018 @02:29 PM
Researchers conducted a thematic analysis of internet posts to summarize the desired and adverse effects of the designer benzodiazepine, flubromazolam.

Mar 13, 2018 @01:17 PM
The etiology, poisoning, and treatment of various marine toxins.

Feb 6, 2018 @02:00 PM
Hearing loss can result from numerous therapeutic drugs and industrial chemicals.

Jan 27, 2018 @05:00 PM
The medical or intentional misuse of this common household agent can have serious consequences.

Jan 12, 2018 @07:30 PM
Based on the outcomes of Checkmate-238, the Food and Drug Administration approved nivolumab as adjuvant therapy for the treatment of melanoma.

Nov 22, 2017 @02:00 PM
The National Kidney Foundation’s Dietary Guidelines for adults starting on hemodialysis instructs patients to avoid this tropical treat. Why?

Sep 29, 2017 @04:21 AM
FDA expands approved indications for ibrutinib in August 2017.

Sep 21, 2017 @02:05 AM
5-Fluorouracil is the mainstay of treatment for many cancers, with upwards of 30% rates of adverse effects. DPD deficiency can further amplify these effects and even lead to life-threatening toxicity. Uridine triacetate is FDA approved for 5-FU and capecitabine overdose treatment within 96 hours of administration.

Sep 11, 2017 @01:16 AM
In 2015, American poison centers responded to more than 10,000 tricyclic antidepressant exposures. With this level of prevalence, pharmacists should be prepared to respond to questions regarding TCA toxicity.

Aug 2, 2016 @08:28 AM
How does your pharmacy keep employees happy?

Jul 15, 2016 @02:55 AM
Patients benefit when pharmacists thoroughly assess pain.

Jun 21, 2016 @03:34 AM
Is your organization prepared to handle a cyber attack?

Jun 14, 2016 @12:23 PM
Is diversity a business strategy in your organization?

Jun 9, 2016 @12:39 PM
As the roles of pharmacists expand, so do opportunities for nontraditional practice settings.

May 31, 2016 @02:12 AM
Regardless of the outcome, all parties must be prepared to handle the implications of the DEA's decision.

May 23, 2016 @02:49 AM
Once you've decided that you want to participate in research, start early and enter with a goal in mind.

May 18, 2016 @01:32 AM
Transformational leadership may be too much of a good thing.

May 9, 2016 @08:00 AM
The Connecticut General Assembly has voted to expand medical marijuana access to patients younger than 18 years.

Apr 12, 2016 @03:11 AM
There's a pressing need for patients and health care professionals to quickly recognize and act on the signs of opioid overdose and withdrawal.

Mar 28, 2016 @06:44 AM
Pharmacists must address questions and fears that patients have about the flu vaccine.

Mar 24, 2016 @04:00 AM
Bristol-Myers Squibb recently announced that it's acquiring Padlock Therapeutics, Inc.

Mar 17, 2016 @09:21 AM
One of the most under-recognized and under-addressed barriers to safe and effective care is low vision.

Feb 26, 2016 @02:24 AM
Pharmacokinetic differences in newborns and infants affect drug selection and dosing.

Feb 2, 2016 @03:28 AM
Pharmacists are in pivotal positions to reduce morbidity and lower health costs by assessing and counseling elderly patients at risk for falls.

Jan 13, 2016 @02:24 AM
In a study published in JAMA Internal Medicine, researchers examined whether opioid duration of action is related to risk of unintentional overdose (OD) injury.